Abstract:Xanthine oxidase inhibitors (XOIs) have been widely studied due to the promising potential as safe and effective therapeutics in hyperuricemia and gout. Currently, available XOI molecules have been developed from different experiments but they are with the wide structure diversity and significant varying bioactivities. So it is of great practical significance to present a consensual QSAR model for effective bioactivity prediction of XOIs based on a systematic compiling of these XOIs across different experiments. In this work, 249 XOIs belonging to 16 scaffolds were collected and were integrated into a consensual dataset by introducing the concept of IC 50 values relative to allopurinol (RIC 50 ). Here, extended connectivity fingerprints (ECFPs) were employed to represent XOI molecules. By performing effective feature selection by machine-learning method, 54 crucial fingerprints were indicated to be valuable for predicting the inhibitory potency (IP) of XOIs. The optimal predictor yields the promising performance by different cross-validation tests. Besides, an external validation of 43 XOIs and a case study on febuxostat also provide satisfactory results, indicating the powerful generalization of our predictor. Here, the predictor was interpreted by shapely additive explanation (SHAP) method which revealed several important substructures by mapping the featured fingerprints to molecular structures. Then, 15 new molecules were designed and predicted by our predictor to show superior IP than febuxostat. Finally, molecular docking simulation was performed to gain a deep insight into molecular binding mode with xanthine oxidase (XO) enzyme, showing that molecules with selenazole moiety, cyano group and isopropyl group tended to yield higher IP. The absorption, distribution, metabolism, excretion and toxicity (ADMET) prediction results further enhanced the potential of these novel XOIs as drug candidates. Overall, this work presents a QSAR model for accurate prediction of IP of XOIs, and is expected to provide new insights for further structure-guided design of novel XOIs.

Virtual-screening of Xanthine Oxidase Inhibitory Peptides: Inhibition Mechanisms and Prediction of Activity Using Machine-Learning

A Consensual Machine-Learning-assisted QSAR Model for Effective Bioactivity Prediction of Xanthine Oxidase Inhibitors Using Molecular Fingerprints

Virtual Screening and Structure Optimization of Xanthine Oxidase Inhibitory Peptides from Whole Protein Sequences of Pacific White Shrimp Via Molecular Docking

Xanthine oxidase inhibitors: Virtual screening and mechanism of inhibition studies

Various machine learning approaches coupled with molecule simulation in the screening of natural compounds with xanthine oxidase inhibitory activity

Xanthine Oxidase Targeted Model Setup and Its Application for Antihyperuricemic Compounds Prediction by in Silico Methods

Using deep learning and molecular dynamics simulations to unravel the regulation mechanism of peptides as noncompetitive inhibitor of xanthine oxidase

Exploration, Sequence Optimization and Mechanism Analysis of Novel Xanthine Oxidase Inhibitory Peptide from Ostrea Rivularis Gould.

Quantitative Prediction of Thiazole Derivatives as Potent Xanthine Oxidase Inhibitors

Antihyperuricemic Activity and Inhibition Mechanism of Xanthine Oxidase Inhibitory Peptides Derived from Whey Protein by Virtual Screening.

In Silico Identification and Experimental Validation of Two Types of Angiotensin-Converting Enzyme (ACE) and Xanthine Oxidase (XO) Milk Inhibitory Peptides

Identification and Anti-Hyperuricemic Activity of Xanthine Oxidase Inhibitory Peptides from Pacific White Shrimp and Swimming Crab Based on Molecular Docking Screening.

Xanthine Oxidase Inhibitory Peptides from Larimichthys polyactis: Characterization and In Vitro/In Silico Evidence

Novel hemoglobin-derived xanthine oxidase inhibitory peptides: Enzymatic preparation and inhibition mechanisms

Identification of Natural Xanthine Oxidase Inhibitors: Virtual Screening, Anti-Xanthine Oxidase Activity, and Interaction Mechanism.

Novel Xanthine Oxidase Inhibitory Peptides Derived from Whey Protein: Identification, in Vitro Inhibition Mechanism and in Vivo Activity Validation

Study on the Activity of Non-Purine Xanthine Oxidase Inhibitor by 3D-Qsar Modeling and Molecular Docking

Exploration of Novel Non-Purine Xanthine Oxidase Inhibitors Based on Oxadiazolones by an Integrated Simulation Study

Systematic investigation of the amino acid profiles that are correlated with xanthine oxidase inhibitory activity: Effects, mechanism and applications in protein source screening

In Silico Rational Design and Virtual Screening of Antixoidant Tripeptides Based on 3D-QSAR Modeling

Predictive Modeling of Angiotensin I-Converting Enzyme Inhibitory Peptides Using Various Machine Learning Approaches.